NASDAQ:MGRM - Nasdaq - US6097861081 - Common Stock - Currency: USD
NASDAQ:MGRM (4/23/2025, 12:58:36 PM)
2.79
+0.16 (+6.08%)
The current stock price of MGRM is 2.79 USD. In the past month the price decreased by -7.39%. In the past year, price increased by 8.1%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.15 | 225.06B | ||
ISRG | INTUITIVE SURGICAL INC | 64.73 | 177.18B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.88 | 148.07B | ||
SYK | STRYKER CORP | 29.63 | 137.85B | ||
MDT | MEDTRONIC PLC | 15.71 | 107.60B | ||
BDX | BECTON DICKINSON AND CO | 14.65 | 58.50B | ||
EW | EDWARDS LIFESCIENCES CORP | 26.93 | 41.48B | ||
IDXX | IDEXX LABORATORIES INC | 38.44 | 35.04B | ||
RMD | RESMED INC | 24.55 | 31.87B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 14.54 | 29.89B | ||
DXCM | DEXCOM INC | 41 | 26.53B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.41 | 23.02B |
Monogram Technologies, Inc. is a medical technology company, which intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company is headquartered in Brooklyn, New York and currently employs 27 full-time employees. The company went IPO on 2023-05-18. The firm is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The firm intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The firm is also exploring other clinical and commercial applications for the mBos with mVision navigation.
MONOGRAM TECHNOLOGIES INC
53 Bridge Street Unit 507
Brooklyn NEW YORK US
Employees: 28
Company Website: https://www.monogramtechnologies.com/
Investor Relations: https://ir.monogramorthopedics.com/
Phone: 17185763205
The current stock price of MGRM is 2.79 USD. The price increased by 6.08% in the last trading session.
The exchange symbol of MONOGRAM TECHNOLOGIES INC is MGRM and it is listed on the Nasdaq exchange.
MGRM stock is listed on the Nasdaq exchange.
7 analysts have analysed MGRM and the average price target is 5.81 USD. This implies a price increase of 108.39% is expected in the next year compared to the current price of 2.79. Check the MONOGRAM TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MONOGRAM TECHNOLOGIES INC (MGRM) has a market capitalization of 98.46M USD. This makes MGRM a Micro Cap stock.
MONOGRAM TECHNOLOGIES INC (MGRM) currently has 28 employees.
MONOGRAM TECHNOLOGIES INC (MGRM) has a support level at 2.44 and a resistance level at 2.71. Check the full technical report for a detailed analysis of MGRM support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MGRM does not pay a dividend.
MONOGRAM TECHNOLOGIES INC (MGRM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.51).
The outstanding short interest for MONOGRAM TECHNOLOGIES INC (MGRM) is 0.56% of its float. Check the ownership tab for more information on the MGRM short interest.
ChartMill assigns a technical rating of 3 / 10 to MGRM. When comparing the yearly performance of all stocks, MGRM turns out to be only a medium performer in the overall market: it outperformed 69.01% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to MGRM. No worries on liquidiy or solvency for MGRM as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months MGRM reported a non-GAAP Earnings per Share(EPS) of -0.51. The EPS decreased by -10.61% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -92.73% | ||
ROE | -113.62% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to MGRM. The Buy consensus is the average rating of analysts ratings from 7 analysts.